Assignee
VACCINEX INC
US42 patents
Top patents by PatentIndex Score
US9828435B2Nov 28, 2017
Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency
VACCINEX INC22 citations94
US9243068B2Jan 26, 2016
Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases
VACCINEX INC25 citations94
US7919594B2Apr 5, 2011
Human anti-CD100 antibodies
VACCINEX INC55 citations94
US9676840B2Jun 13, 2017
Anti-CD100 neutralizing antibodies and methods of using the same
VACCINEX INC11 citations92
US9605055B2Mar 28, 2017
Anti-CD100 antibodies and methods of using the same
VACCINEX INC14 citations92
US9090709B2Jul 28, 2015
Anti-SEMA4D antibodies and epitopes
VACCINEX INC18 citations92
US7919095B2Apr 5, 2011
Anti-IL-6 monoclonal antibodies
VACCINEX INC27 citations92
US9598495B2Mar 21, 2017
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
VACCINEX INC16 citations91
US9249227B2Feb 2, 2016
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
VACCINEX INC18 citations91
US8790652B2Jul 29, 2014
Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis
VACCINEX INC20 citations88
US9890213B2Feb 13, 2018
Methods for the treatment of B cell-mediated inflammatory diseases
VACCINEX INC10 citations84
US9790271B2Oct 17, 2017
Methods for increasing immunoglobulin A levels
VACCINEX INC10 citations84
US9512224B2Dec 6, 2016
Use of semaphorin-4D binding molecules for treatment of atherosclerosis
VACCINEX INC11 citations84
US10111950B2Oct 30, 2018
Modified glycolipids and methods of making and using the same
VACCINEX INC5 citations83
US9371352B2Jun 21, 2016
Modified glycolipids and methods of making and using the same
VACCINEX INC10 citations83
US9708601B2Jul 18, 2017
Fusion proteins to facilitate selection of cells infected with specific immunoglobulin gene recombinant vaccinia virus
VACCINEX INC7 citations80
US10800853B2Oct 13, 2020
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
VACCINEX INC1 citations72
US10385136B2Aug 20, 2019
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
VACCINEX INC3 citations72
US10301393B2May 28, 2019
Methods of treating multiple sclerosis using anti-CD20 antibodies
VACCINEX INC4 citations72
US11078295B2Aug 3, 2021
Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases
VACCINEX INC2 citations71
US11427634B2Aug 30, 2022
Human anti-semaphorin 4D antibody
VACCINEX INC4 citations70
US9701958B2Jul 11, 2017
Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunits
VACCINEX INC4 citations69
US10577427B2Mar 3, 2020
Integral membrane protein display on poxvirus extracellular enveloped virions
VACCINEX INC3 citations68
US10550199B2Feb 4, 2020
Integral membrane protein display on poxvirus extracellular enveloped virions
VACCINEX INC2 citations68
US11597765B2Mar 7, 2023
Use of semaphorin-4D binding molecules for the treatment of Rett syndrome
VACCINEX INC2 citations67
US11859000B2Jan 2, 2024
Anti-CCR8 antibodies and uses thereof
VACCINEX INC3 citations66
US12070500B2Aug 27, 2024
Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis
VACCINEX INC0 citations62
US12006364B2Jun 11, 2024
Anti-CD100 antibodies and methods for using the same
VACCINEX INC0 citations62
US11534488B2Dec 27, 2022
Use of semaphorin-4D binding molecules for modulation of blood brain barrier permeability
VACCINEX INC1 citations62
US11274149B2Mar 15, 2022
Anti-CD100 antibodies and methods for using the same
VACCINEX INC0 citations62
US12006365B2Jun 11, 2024
Human anti-semaphorin 4D antibody
VACCINEX INC1 citations59
US11981730B2May 14, 2024
Anti-CXCL13 antibodies and methods of using the same
VACCINEX INC0 citations59
US11572408B2Feb 7, 2023
Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic modulating agent
VACCINEX INC0 citations58
US12496342B2Dec 16, 2025
Anti-CCR8 antibodies and uses thereof
VACCINEX INC0 citations55
US10526414B2Jan 7, 2020
Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases
VACCINEX INC0 citations52
US10494440B2Dec 3, 2019
Use of semaphorin-4D binding molecules to promote neurogenesis following stroke
VACCINEX INC0 citations52
US11976383B2May 7, 2024
Integral membrane protein display on poxvirus extracellular enveloped virions
VACCINEX INC0 citations51
US10829550B2Nov 10, 2020
Polynucleotides encoding anti-CXCL13 antibodies
VACCINEX INC0 citations48
US10870707B2Dec 22, 2020
Integral membrane protein display on poxvirus extracellular enveloped virions
VACCINEX INC0 citations47
US10662422B2May 26, 2020
Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunit
VACCINEX INC0 citations46
US7807168B2Oct 5, 2010
Selection of human TNFα specific antibodies
VACCINEX INC0 citations38
US10640765B2May 5, 2020
Methods for producing polynucleotide libraries in vaccinia virus/eukaryotic cells
VACCINEX INC0 citations29